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Both sequence variation and copy-number variation (CNV) of the genes encoding receptors for immunoglobulin G (Fcg receptors) have
been genetically and functionally associated with a number of autoimmune diseases. However, the molecular nature and evolutionary
context of this variation is unknown. Here, we describe the structure of the CNV, estimate its mutation rate and diversity, and place it in
the context of the known functional alloantigen variation of these genes. Deletion of Fcg receptor IIIB, associated with systemic lupus
erythematosus, is a result of independent nonallelic homologous recombination events with a frequency of approximately 0.1%. We
also show that pathogen diversity, in particular helminth diversity, has played a critical role in shaping the functional variation at these
genes both between mammalian species and between human populations. Positively selected amino acids are involved in the interac-
tion with IgG and include some amino acids that are known polymorphic alloantigens in humans. This supports a genetic contribution
to the hygiene hypothesis, which states that past evolution in the context of helminth diversity has left humans with an array of suscep-
tibility alleles for autoimmune disease in the context of a helminth-free environment. This approach shows the link between pathogens
and autoimmune disease at the genetic level and provides a strategy for interrogating the genetic variation underlying autoimmune-
disease risk and infectious-disease susceptibility.Introduction
The human immune system is subject to natural selection
shaped by pathogenic and commensal microorganisms.1
The interaction between antibody-antigen complexes
and cells that mediate the immune response is a critical
stage that determines both the nature and magnitude of
that response. Fcg receptors are cellular receptors for the
Fc domain of immunoglobulin G. Upon binding to anti-
bodies, Fcg receptors typically transmit an intracellular
signal through either phosphorylation of immunoreceptor
tyrosine-based activation motifs (ITAMs) or inhibitory
motifs (ITIMs).2 In humans, two tandem paralogous
repeats contain the genes FCGR3A (MIM 146740) and
FCGR3B (MIM 610665), encoding two variants (Fcg
receptor IIIA and Fcg receptor IIIB, respectively) of the
low-affinity activating receptor Fcg receptor III
(Figure 1A).3 The proteins that these two paralogous genes
encode differ both in their attachment to the cell
membrane and in their expression pattern. Fcg receptor
IIIA has a transmembrane region and is expressed on
natural killer (NK) cells, monocytes, dendritic cells, and
macrophages. Fcg receptor IIIB is truncated by an argi-
nine-to-stop mutation, is attached to the cell membrane
by a glycophosphoinositol anchor, and is expressed on
neutrophils, mast cells, and eosinophils.4
Three other genes encoding Fcg receptors are in this
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The Am604590) code for activating (Fcg receptor IIA) and inhibi-
tory (Fcg receptor IIB) receptors, respectively. They flank
the two paralogous repeats on the proximal and distal
sides, respectively, but do not show CNV.5 A third Fcg-
receptor gene, FCGR2C (MIM 612169), is a fusion gene
formed from the 50 end of FCGR2B and the 30 end of
FCGR2A6 and spans the breakpoint between the two
paralogous repeats. The activating receptor that it encodes
is expressed on NK cells and is involved in the generation
of antibody-dependent cellular cytotoxicity (ADCC).7
However, this protein is expressed only in a subset of indi-
viduals: A common polymorphism (FCGR2C c.169C>T
[p.Gln57*]) changes a glutamine to a stop codon and
causes premature truncation of the protein and abolishes
expression of this receptor on the cell surface.8
Both sequence and CNV of these genes have been
shown to affect function and have been associated with
autoimmune disease.9,10 In FCGR3B, two allotypes termed
human neutrophil antigen 1a (HNA1a) and HNA1b differ
at four amino acid positions and in their ability to phago-
cytose opsonised particles.11 Both HNA1 types and
FCGR3B CNV are independently associated with systemic
lupus erythamatosus (SLE [MIM 152700]),12,13 and copy
number itself is associated with rheumatoid arthritis.14–16
For FCGR2A, coding polymorphism rs1801274 has been
associated with Kawasaki disease (MIM 611775) in
a genome-wide association analysis.17 For FCGR2B,
a coding polymorphism (rs1050501) affects the ability ofol of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK;
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Figure 1. Schematic Diagram of the Low-Affinity-Region Fcg Receptor in Humans
(A) The cluster of low-affinity-region Fcg-receptor genes in chromosomal region 1q23.3. The location of the genes, the position of the
segmental duplications, the locations of SNPs analyzed, and the copy-number assays used are shown. The gradient shading on segmental
duplication B reflects the gradual decrease in sequence identity rather than a clear transition from duplicated to single-copy sequence.
The dashed lines for the HNA1a/b and FCGR2C p.Gln57* assays indicate that both paralogs are amplified by these primers, but the rele-
vant variation is only on one paralog.
(B) A model of how NAHR could generate FCGR3B-deletion chromosomes by unequal crossing over between the two segmental dupli-
cations. In this case, the NAHR breakpoint is proximal to FCGR3, generating a deletion of FCGR3A.
(C) A model of how NAHR could generate FCGR3A-deletion chromosomes by unequal crossing over between the two segmental dupli-
cations. In this case, the NAHR breakpoint is distal to FCGR3, generating a deletion of FCGR3B.Note that whether FCGR3A or FCGR3B is
deleted is only due to the position of the NAHR breakpoint.its receptor to associate with lipid rafts, impairs its inhibi-
tory function, and is a susceptibility allele for SLE and is
protective against malaria.18–20 For FCGR2C, the active
allele is associated with the hematological autoimmune
disease idiopathic thrombocytopenic pupura (MIM
188030) and with rheumatoid arthritis severity.21
We decided to address some of the outstanding questions
concerning this complex disease-associated region. The
nature of the CNV was not clear; limited sizing of a few
deletion and duplication alleles supported a model of loss
or gain of whole repeat units 82 kb in length by nonallelic
homologous recombination (NAHR).22 However, some
reports suggested CNV of different lengths generated by
alternative mechanisms.5,19 Given the evidence for this
region containing several susceptibility alleles for several
autoimmune diseases, we also asked whether there is any
evidence for the hygiene hypothesis,23 which states that
past pathogen-driven selection has left a legacy of suscepti-
bility alleles for autoimmune diseases in the context of974 The American Journal of Human Genetics 90, 973–985, June 8, 2a pathogen-poor modern environment. In this paper, we
determine the nature and rate of CNV mutation, investi-
gate the global variation of disease-associated variation at
this locus, and explore evolutionary hypotheses explaining
the variation at this locus.Material and Methods
Samples
DNA samples were purchased from Coriell Cell Repositories
(HapMap) or from CEPH-HGDP (CEPH-obtained samples from
the Human Genome Diversity Panel24,25). Genotype data from
the HGDP sample series for seven SNPs (rs723177, rs1256286,
rs11801845, rs1832739, rs6697139, rs1340976, and rs4657090)
were previously published and were downloaded via the portal
SPSmart.26,27 Throughout this paper, the HapMap population
identifiers CEU (Utah residents with ancestry from northern and
western Europe from the CEPH collection) and YRI (Yoruba from
Ibadan, Nigeria) are used.012
Copy-Number Typing
We typed copy number of FCGR3A and FCGR3B and genotyped
the HNA1a and HNA1b alleles by using a combination of the
paralog ratio test (PRT) and restriction-enzyme-digest variant ratio
(REDVR) assay essentially as described previously.22,28 In addition
to the published assays, variant-ratio information from the
FCGR2C p.Gln57* assay (see below) was also incorporated
into the maximum-likelihood copy-number calling approach,
improving the power of accurate copy-number calls. It is impor-
tant to note that these assays are not paralog specific because
the primers are designed to amplify both paralogs. The assays
thus have the advantage of being insensitive to the position of
the deletion or duplication breakpoints generated by NAHR, and
they therefore determine the copy number regardless of the nature
of the CNV generated by NAHR.Sequence Polymorphism Assays
FCGR2C has a SNP (rs10917661; c.169C>T) that changes a gluta-
mine to a stop codon at amino acid position 57 (p.Gln57*),
which is in the first extracellular domain, and this SNP was
assayed by PCR amplification with 0.5 mM of each primer pair
(50 -CAACTGCCTTCAGTTGCAGA-30 and 50 NED-GTTGTTGGCC
TTGAACCTGT-30). Products were amplified from 10 ng genomic
DNA with 26 cycles each of the following: 95C for 30 s, 60C
for 30 s, and 70C for 30 s; these cycles were followed by a single
chase phase of 60C for 1 min and 70C for 20 min so that the
levels of single-stranded DNA products would be reduced. 5 ml of
PCR product was then digested with 2.5 units of BfaI restriction
enzyme (New England Biolabs) in 20 mM Tris-acetate (pH 7.9 at
25C), 50 mM potassium acetate, 100 mM NaCl, 10 mM magne-
sium acetate, and 1 mM dithiothreitol in a final volume of 10 ml
for 3 hr at 37C. 1 ml of product was then analyzed by capillary
electrophoresis with the Applied Biosystems (ABI) 3130xl genetic
analyzer. This assay, together with the FCGR3B HNA1 assay previ-
ously published, is not paralog specific, and it is assumed that the
variation occurs only on the A paralog (for this assay) and the B
paralog (for the FCGR3B HNA1 assay). We have no examples of
REDVR data that call this assumption into doubt. Also, there is
no published genetic or functional evidence that the stop-codon
allele of FCGR2C is transferred by gene conversion to FCGR2B
(which would generate a null FCGR2B allele) or that the HNA1
allele is transferred to FCGR3A, which is also very likely to have
functional consequences. However, we cannot rule out rare
instances of this occurring by gene conversion, which would not
be detected by our methods.
For both the HNA1a/HNA1b locus and the FCGR2C p.Gln57*
locus, population allele frequencies cannot be deduced in
a straightforward manner given that they are not always diploid
loci. We derived a mean value for HNA1a and FCGR2C Gln57 for
each population, as previously published22, from individual-level
data reflecting the relative proportions of each variant in that indi-
vidual. For example, a HNA1a-HNA1b genotype has a value of 0.5,
and a HNA1a-HNA1a-HNA1b genotype has a value of 0.66.
The FCGR2B SNP (rs1050501) was assayed by PCR amplification
with 0.5 mM of each primer pair (50 HEX-GAAGAGCTTCGGGTGA
CAAG-30 and 50-CAACAATGGCCGCTACTGCA-30) designed to
amplify both duplications. Products were amplified from 10 ng
genomic DNA with 30 cycles each of the following: 95C for
30 s, 69C for 30 s, and 70C for 30 s; these cycles were followed
by a single chase phase of 69C for 1 min and 70C for 20 min.
2 ml of PCR product was subsequently digested with 5 units ofThe AmPstI restriction enzyme (New England Biolabs) in 50 mM Tris-Cl
(pH 7.9 at 25C), 100 mMNaCl, 10 mMMgCl2, and 1 mM dithio-
threitol in a final volume of 10 ml for 3hr at 37C. 1 ml was then
analyzed by capillary electrophoresis with the ABI 3130xl genetic
analyzer; product peaks were quantified and genotypes were deter-
mined on the assumption that only FCGR2B showed variation. To
confirm this assumption, we also genotyped this SNP by using
a previously published paralog-specific sequencing-based assay.20Phasing of Haplotypes
HapMap SNP data for eight SNPs were combined with the CNV
data previously published,22 and the HGDP SNP data were gener-
ated and described here. HapMap trios for which no data existed
for these SNPs as well as three trios for which there was evidence
of non-Mendelian inheritance of the CNV region as a result of
either de novo mutation events or CNV typing error were
removed. This left 11 CEU trios and 14 YRI trios, which were
combined with seven trios (one Columbian, one Karitiana, two
Melanesian, one Pima, and two Surui) from the HGDP sample
set and phased with PHASE 2.1.29
The parental haplotypes, phased from trio data, were then
combined with the unrelated individual genotypes from the
HGDP panel and were annotated as known haplotype phases
with the -k option. This ‘‘seeding’’ of the unrelated genotype
data with known haplotypes prior to phasing increases the power
of PHASE to predict haplotypes in unrelated individuals (Figure S1,
available online). For BATWING analysis, this phasing was
repeated only for YRI trio samples.Breakpoint Mapping of Deletion Alleles
Paralogous sequence variants (PSVs) were identified as differences
between the two copies of the FCGR3 duplication mapped in
human genome assembly hg18. Although some of these putative
PSVs will represent SNPs on one paralog, the percent divergence
(1.5%) between the two paralogs supports a duplication event
prior to human speciation, so the vastmajority of these differences
are likely to be true PSVs, i.e., fixed between the two paralogs. Indi-
viduals homozygous for deletions (i.e., those with only two copies
of FCGR3A or FCGR3B) were identified from the HGDP. Sixteen
overlapping PCR products spanning the 82 kb duplication were
generated with primer pairs detailed in Table S1. Primers were de-
signed to coamplify both A and B paralogous sequences. Long
PCRs were done in 25 ml reactions on a Veriti thermal cycler
(ABI) with the buffer described previously30 and were supple-
mented with 0.2 mM of each primer, 0.025U Taq DNA polymerase
(Kapa Biosystems), and 0.0033U PfuDNApolymerase (Stratagene).
Products were amplified from 10 ng genomic DNA with an initial
denaturation of 94C for 1 min, a first stage consisting of 23 cycles
each of 94C for 15 s and 68C for 10 min, and a second stage con-
sisting of 12 cycles each of 94C for 15 s and 68C for 10 min (plus
15 s/cycle); these were followed by a single chase phase of 72C for
10 min. Amplicons were resolved by agarose gel electrophoresis,
were gel extracted (QIAGEN), and were Sanger end sequenced
for determining which amplicon contained a junction (identified
by a switch in PSV identity). Internal sequencing primers were
then used for mapping the exact breakpoint. In some cases, there
was complexity caused by putative historic gene-conversion
events that made determining the exact junction boundary
impossible, and this is highlighted in Figure 2.
We identified one individual (HGDP00958, Yakut) who had one
copy of FCGR3A and one copy of FCGR3B and who showed noerican Journal of Human Genetics 90, 973–985, June 8, 2012 975
Figure 2. Analysis of Deletion Breakpoints in
Different Deletion Chromosomes
(A) The FCGR3 duplication in humans. The posi-
tions of the overlapping PCR amplicons used for
spanning and amplifying both duplications are
shown in pale blue and are relative to the hg18
chromosome 1 coordinates. Also shown are the
density of paralogous sequence variants (PSVs)
between FCGR3A and FCGR3B duplications in
dark blue, RefSeq genes, and the positions of the
deletion breakpoints found.
(B) Detailed analysis of deletion breakpoints in
homozygous deletion-positive individuals. For
each individual, both alleles (labeled as 1 and 2
on the right of each diagram) are shown. The
overlapping PCR amplicons spanning the dupli-
cation are shown in the center, and the amplicon
number indicates the amplicon in which that
particular breakpoint was found. Each amplicon
containing the breakpoint is expanded (shown
by the blue brackets above and below the PCR
amplicons) and shows the position of the PSVs
as well as the hg18 chromosome 1 coordinates.
A change in color from red (A-like PSVs) to blue
(B-like PSVs) indicates the breakpoint. If the
breakpoint position is not clear because of gene-
conversion events or possible recurrent NAHR
events, the PSVs in the putative breakpoint region
are colored black. The identification number of
the individual is shown together with the popula-
tion of origin and the letter code representing the
eight-SNP haplotypes (Table S2).evidence of any deletion breakpoint, as identified by a switch from
A-like PSVs to B-like PSVs. We interpret this individual as having
a large deletion of both FCGR3A and FCGR3B on one of the two
homologous chromosomes. This deletion allele is likely to be
extremely rare given that it will result in a two-copy genotype
when paired with a two-copy allele and in a one-copy genotype
when paired with a one-copy allele. We have not seen any one-
copy individuals in over 1,500 samples analyzed, and the fact
that we have seen only one such two-copy individual is consistent976 The American Journal of Human Genetics 90, 973–985, June 8, 2012with a estimation of the frequency of the null
allele at around 0.1%, which differs from the
estimated global frequency of NAHR-generated
deletion alleles of around 6.5% (calculated with
ConVem31 assuming Hardy-Weinberg equilib-
rium [Table S2]). We are currently investigating
the exact nature of this rare allele.
Estimation of Mutation Rate
The mutation rate of the copy-number variable
region was estimated from YRI population data
via BATWING. The YRI population was chosen
because it has not experienced the out-of-Africa
range-expansion demographic event. FCGR3A
and FCGR3B copy-number estimates were from
a previously published dataset in which the
copy number of FCGR3A and FCGR3B were
considered together because the distinction
between FCGR3A CNV and FCGR3B CNV
depends only on the position of the breakpoint
of NAHR. Eight-SNP haplotypes were calculated
from the trio data, and all haplotypes had a poste-rior probability of 1. One SNP (rs1050501) was found to break the
four-gamete rule,32 indicating either historical recombination or
gene conversion, and was removed from the dataset.
BATWING uses a Bayesian Markov-chain Monte Carlo coales-
cent approach to generate approximate posterior distributions of
population parameters, such as mutation rate, and incorporates
a model of exponential population expansion from a constant
ancestral population size; this model was used here.33 BATWING
allows two classes of locus (with different mutation rates) that
usually reflect SNPs and short tandem repeats (STRs). The data
used here, in which haplotypes consist of a highly variable CNV
and less variable SNPs, are analogous to an SNP-STR model. This
is especially true given that the CNV mutation is due to NAHR,
and the locus is therefore likely to follow a stepwise mutation
model, which was developed for describing mutational processes
at STRs.
The prior probability distribution for effective population size
(Ne) was a normal distributionwith amean of 7,200 and a standard
deviation of 1,600. This prior distribution, based on an estimate of
the effective population size of the YRI population from linkage-
disequilibrium data, is likely to represent an estimate of Ne from
more recent population history and a more appropriate estimate
of the current Ne used by BATWING.
34 The population expansion
parameter a was given a prior probability distribution after
a gamma distribution (scale parameter ¼ 2, shape parameter ¼
400), and the prior distribution of themutation rate was a uniform
distribution between 1 3 106 and 1 3 103.Analysis of Pathogen Richness
On the basis of the Gideon database, pathogen absence or pres-
ence matrices were constructed for the 21 countries where the
HGDP populations are located as described previously.35,36 In
brief, pathogen diversity was calculated from these data for each
population, and only species or genera that are transmitted in
the 21 countries were taken into account (cases of transmission
caused by tourism and immigration were not taken into account);
also, species that had recently been eradicated as a result of vacci-
nation campaigns, for example, were recorded as present in the
matrix. Malaria prevalence was obtained from either the Gideon
or World Health Organization (WHO) databases as previously
described.37 In order to account for the demographic history of
human populations, we calculated correlations by using partial
Mantel tests. Specifically, matrices were computed as pairwise
Euclidean distances in variant frequency, distances from east
Africa, and pathogen diversity or malaria prevalence (from either
the WHO or the Gideon database). Distances from Africa were
derived from a previous work38 and refer to a model of human
migration that progressed from east Africa along landmasses while
avoiding mountain regions with altitudes over 2,000 m.We calcu-
lated the statistical significance of correlation tests by performing
10,000 permutations of pathogen diversity or malaria prevalence
within continental regions; these regions were defined as previ-
ously suggested26 (i.e., Africa, Europe, America, central South
Asia, East Asia, and Oceania), and Middle Eastern populations
were grouped with Europeans. Partial Mantel correlations were
performed with the VEGAN R package.
Genus data on helminth richness were taken from a previously
published paper.39 In brief, the total number of helminth species
recovered from all individual hosts within a genus (often reflecting
several different species) was collected. This value was corrected
for sample size. It should be noted that only gastrointestinal
helminths were assayed in this analysis.Phylogenetic Analysis
Putative orthologous DNA sequences of FCGR3 were identified
with the Gene Orthology prediction method implemented in
the Ensembl genome browser. In addition, mRNA sequences
were obtained from the National Center for Biotechnology Infor-
mation (NCBI) nucleotide database. Sequences were aligned with
ClustalW, and a tree was generated by maximum likelihood withThe Amthe DNA Maximum Likelihood (DNAML) program, part of the
PHYLIP 3.6 suite of programs.40 After the removal of initiation
codons, stop codons, and deletions within the alignment, codon
sequences were analyzedwith Phylogenetic Analysis byMaximum
Likelihood (PAML) v.4.4b (assuming no molecular clock), an F84
base substitution model, and a guide tree based on the accepted
phylogeny of the species concerned.41
By fitting the data to two likelihood models, M1a and M2a, in
PAML, we have a test of whether positive selection, as defined
by u > 1, has acted on a gene. M1a is the model assuming a null
hypothesis that all codons fall into two classes: (1) those that
evolve neutrally (u ¼ 1) or (2) those that evolve with purifying
selection (0 < u <1). M2a allows codons to fall into another class:
those showing positive selection (u > 1). Therefore, by comparing
the log likelihood of the data-fittingmodel M1a with the log likeli-
hood of the data-fitting model M2a, we obtain a significance level
testing the hypothesis that certain amino acids are under positive
selection. We derive the significance value by calculating 23(log
likelihood M1a  log likelihood M2a) and by comparing that
figure with a c2 distribution with 2 degrees of freedom. Codons
under positive selection were mapped to the crystal structure of
FCGR3B in complex with an Fc fragment of IgG1 (RCSB PDB
ID: 1T83) with PyMOL 1.2.
To test the influence of high helminth diversity, we labeled the
branches on the guide tree as having high helminth diversity if
they led to a genus that had a helminth-diversity value greater
than the median. A branch-site test model A was run, which fits
model M2a twice by once allowing u to vary along the high-
helminth branches and by once fixingu¼ 1 along these branches,
for the third class of codon site.We derive the significance value by
doubling the log-likelihood difference between the two models
and by comparing that figure with a c2 distribution with 1 degree
of freedom.Results
Global Analysis of Variation Associated with
Inflammatory Disease
We typed FCGR3A and FCGR3B copy number, rs76714703
(encoding HNA1a/b), rs10917661 (FCGR2C c.169C>T
[p.Gln57*]), and rs1050501 (FCGR2B c.695T>C
[p.Ile232Thr]) on 946 unrelated samples from 51 popula-
tions and seven continental groups from the HGDP
(Table 1), and we combined these with rs1801274
(FCGR2A c.497A>G [p.His131Arg]) genotypes, previously
genotyped on this sample set. We observed no notable
population differentiation, as measured by FST, nor any
large differences in copy-number distribution (Table 1
and Table S3). One exception was the high frequency of
FCGR3B three-copy individuals observed in South Amer-
ica. It is unclear whether this is a consequence of recent
natural selection, genetic drift, or small sample size, and
further work on South American populations is ongoing.
For the CNV, absence of population structure could be
due to a high CNV mutation rate effectively erasing the
signal of ancient demographic changes, such as the out-
of-Africa range expansion, from CNV diversity. To test
this idea, we used a set of eight SNPs that flanked the
CNV to investigate the recent evolutionary history oferican Journal of Human Genetics 90, 973–985, June 8, 2012 977
Table 1. Geographical Distribution of FCGR Variation
Africa Middle East Europe South Asia East Asia Oceania South America FST
Number of individualsa 103 163 158 201 229 28 64 
Allele or haplotype
FCGR2A His131 0.61 0.47 0.52 0.62 0.71 0.57 0.28 0.048
FCGR3B HNA1a 0.37 0.35 0.40 0.32 0.64 0.72 0.80 0.074
FCGR2C Gln57 0.17 0.23 0.18 0.18 0.05 0.09 0.24 0.011
FCGR2B Thr232 0.28 0.13 0.15 0.15 0.22 0.18 0.02 0.012
FCGR3A copy number 2.00 2.08 1.97 1.99 1.91 1.96 2.05 
FCGR3B copy number 2.29 2.13 2.14 2.17 2.21 2.00 2.47 
A 0.26 0.13 0.14 0.14 0.21 0.18 0.00 
K 0.16 0.13 0.10 0.08 0.01 0.07 0.01 
M 0.16 0.06 0.04 0.08 0.02 0.00 0.01 
R 0.07 0.13 0.22 0.24 0.49 0.59 0.76 
T 0.02 0.24 0.22 0.18 0.01 0.13 0.13 
V 0.20 0.25 0.25 0.22 0.24 0.02 0.07 
Other haplotypes 0.13 0.06 0.03 0.06 0.02 0.01 0.02 
aNumber of individuals tested for all variation except for FCGR2A His131.this locus (Figure 1A). We reasoned that if this CNV does
show a high mutation rate, we would expect to see recur-
rent deletions and duplications of both FCGR3A and
FCGR3B on different eight-SNP haplotypes. We phased
FCGR3A and FCGR3B copy number together with the
eight-SNP haplotypes to obtain likely haplotype pairs for
each HGDP individual. The frequencies of the six most
globally common eight-SNP haplotypes in the seven
different continental groups are consistent with the broad
neutral pattern of human genetic diversity; this pattern,
a consequence of the out-of-Africa range expansion
60,000 years ago, is that high diversity in Africa reduces
as the distance from Africa increases (Table 1 and Table S4).
Duplication and deletion of both FCGR3A and FCGR3B
have occurred on all six common eight-SNP haplotypes
(Table 2). It should be noted that, although the eight-SNP
haplotypes were phased with high posterior probability,
in some cases, copy number could not be reliably assigned
to a particular haplotype in a given haplotype pair
(Figure S1). However, the phasing is likely to be conserva-
tive, favoring the identification of eight-SNP CNV haplo-
types previously observed rather than generating new
combinations of haplotype and copy number. This will
bias the data against observing de novo CNV mutation
events—i.e., new combinations of eight-SNP haplotypes
and copy number. A similar analysis of the single-nucleo-
tide variation within the CNV, namely HNA1a/b and
FCGR2C c.169C>T (p.Gln57*), showed that for both poly-
morphisms, both alleles were observed on all six common
eight-SNP haplotypes (Table 2) as a direct consequence of
recombination, both allelic andnonallelic,within theCNV.978 The American Journal of Human Genetics 90, 973–985, June 8, 2Recurrent CNV Mediated by Nonallelic Homologous
Recombination
We reasoned that if the CNV is recurrent and is mediated
by nonallelic homologous recombination between the
segmental duplications carrying FCGR3A and FCGR3B,
then we would not expect the deletion alleles to be the
result of a single past NAHR event, and we would therefore
expect them to not be identical by descent. Instead, we
would expect the deletion alleles to be the result of several
past NAHR events and to therefore show different NAHR
breakpoints.
To test this hypothesis, we mapped the deletion break-
points in five individuals homozygous for deletions—i.e.,
with only two copies of FCGR3A or FCGR3B. We used
a PCR strategy to generate overlapping amplicons across
the whole 82 kb repeat unit by using primers predicted
to amplify both A and B repeats (Figure 2A). Sanger
sequencing of the ends of these amplicons allowed us to
determine whether each of the two deletion chromosomes
was either the A repeat or the B repeat and at a given site
by examining the PSVs that distinguish A from B. This
allowed us to identify the amplicons containing the break-
points between A and B, and we then completely
sequenced the amplicons to identify the breakpoint.
Figure 2B shows the ten breakpoints identified in five
individuals. Of these breakpoints, two are proximal to
FCGR3 and generate FCGR3A deletions (Figure 1B), and
eight are distal to FCGR3 and generate FCGR3B deletions
(Figure 1C). Fine mapping of the breakpoints shows that
they are all independent events, supported by the observa-
tion that most deletion events have occurred on different012
Table 2. Haplotype Distribution of FCGR Variation Relevant to Disease
SNP Haplotype
FCGR3A Copy Number FCGR3B Copy Number HNA1 FCGR2C
0 1 2þ 0 1 2þ a b * Gln
A 20 277 11 17 257 24 29 187 152 35
K 7 128 5 1 143 6 25 95 58 48
M 1 90 5 5 87 11 44 33 62 7
R 21 529 24 5 439 115 345 38 299 35
T 4 253 2 13 210 36 79 106 158 14
V 37 353 25 7 365 43 98 198 255 6
Table 3. Posterior Distributions of Coalescent Estimates of CNV
Mutation Rate
Parameter
Lower
95% CI Mean
Upper
95% CI
Mutation rate m
(per generation)
2.84 3 104 1.008 3 103 1.384 3 103
Effective population
size N
4,138.18 6,980.128 9,985.66
Time to MRCA of
eight-SNP haplotype
(years)a
7,728 24,736 115,094
The following abbreviations are used: CI, confidence interval; and MRCA, most
recent common ancestor.
aAssuming N ¼ 6,980 and generation time ¼ 25 years.eight-SNP haplotypes. This suggests that most FCGR3A
and FCGR3B deletions, at least when sampled from
different populations, represent distinct mutation events.
These independent breakpoints appear to cluster in two
distinct regions generating either FCGR3A (breakpoint A)
or FCGR3B (breakpoint B) deletions. These are likely to
represent NAHR hotspots similar to those observed at
other loci,42 although HGDP00210 allele 2 shows a break-
point outside these clusters. Analysis of more deletion
alleles will help resolve how many deletion events occur
within these clusters.
Estimation of CNV Mutation Rate from Population
Data
We decided to use a coalescent approach to provide an esti-
mate of the mutation rate at the FCGR3 CNV. Such an
approach has limitations; in particular, it assumes no selec-
tion and a randomly mating population with no demo-
graphic substructure. Both assumptions are certainly
untrue and will affect the coalescent process. However,
the low FST values and lack of linkage disequilibrium
between the CNV and the eight-SNP haplotype suggest
that there has not been a recent selective sweep that would
otherwise distort inferences made from the coalescent.
We simulated the coalescence process by using 52 haplo-
types phased from YRI trio data (all had a phasing posterior
probability of 1). An exponential population-expansion
model was chosen, and prior estimates of the effective pop-
ulation size from linkage-disequilibrium data were from
the YRI population. The expansion parameter is given
a broad prior, similar to other studies, and covers a large
number of possible expansion rates. Posterior estimates
of population parameters with 95% confidence intervals
are shown in Table 3. The CNV mutation rate is estimated
at between 0.03% and 0.14% per generation.
Association between Inflammatory-Disease Variation
and Pathogen Richness
Given the functional relevance of the sequence variation
typed in this study, we reasoned that it was possible that
infectious-disease burden was involved in shaping the
geographic distributionof that variation. To test association
with pathogen diversity, we performed a correlation anal-The Amysis of allele frequency against indices of pathogen diver-
sity, specifically viral, bacterial, protozoan, and helminth
diversity.
The CNVof FCGR3A and FCGR3B showed no association
with pathogen diversity. This is probably due to the lack of
power given the limited variation in average copy number
seen between populations (Table 1), and this limited varia-
tion is itself probably a direct consequence of the high
mutation rate of this locus.
However, two of the nucleotide polymorphisms tested
showed association with one or more of these indices
when corrected for multiple testing. The HNA1a allele is
associated with virus diversity, and the active FCGR2C
Gln57 allele is associated with bacterial diversity (Table 4).
Bothof these alleles are also associatedwithhelminthdiver-
sity, and the FCGR2AHis131 allele shows a nominal associ-
ation. The three polymorphisms should be regarded as
independent evidence of association with helminth diver-
sity; linkage disequilibrium is very unlikely to account for
the shared pattern of association because there is no corre-
lation in allele frequency between HNA1 and the active
FCGR2C allele across the populations analyzed (r2 ¼ 0.03).
Evolution of FCGR3 in Mammals
Given the highly significant correlation between HNA1a
frequency and helminth diversity across 51 human popu-
lations, we sought to support this finding by using compar-
ative sequence data from different mammalian species.erican Journal of Human Genetics 90, 973–985, June 8, 2012 979
Table 4. Variant Characteristics and p Values of the Correlation between Variant Frequency and Pathogen Diversity across Human
Populations
FCGR2A His131 HNA1a FCGR2C Gln57 FCGR2B Thr232
FCGR3A Copy
Number
FCGR3B Copy
Number
Characteristics
SNP rs1801274 rs76714703 rs10917661 rs1050501  
Class of receptor activating activating activating inhibiting activating activating
Functional
consequence
of allele
stronger binding
of IgG2
stronger binding
of IgG1 and IgG3
presence of
receptor on
NK cells
absence of
receptor on
cell surface
variable amount
of receptor on
NK cells
variable amount
of receptor on
neutrophils
Association
with disease
protective against
SLE; susceptibility
to myasthenia gravis;
susceptibility to
Kawasaki disease
protective against
SLE; benign course
of multiple sclerosis
increases idiopathic
thrombocytopenic
purpurea risk
susceptibility to
SLE; protection
against malaria
bacterial
infection
low copy-number
susceptibility to SLE
and rheumatoid
arthritis
Correlation p values
Virus 0.6185 0.0067 0.595 0.1692 0.0624 0.6115
Bacteria 0.0242 0.2744 0.0016 0.5453 0.0518 0.413
Protozoa 0.0140 0.6616 0.4873 0.4345 0.0835 0.2147
Helminth 0.0252 0.0018 0.0005 0.3186 0.083 0.9985
Malaria (WHO) 0.7317 0.4253 0.3927 0.8117 0.1242 0.771
Malaria (Gideon) 0.6466 0.3341 0.2749 0.6941 0.0458 0.7018
The p values in bold remain significant after correction for multiple testing. The following abbreviations are used: WHO, World Health Organization; NK, natural
killer; and SLE, systemic lupus erythematosus.Helminth infection is present across themammalian order,
yet levels of helminth infection, as measured by species
richness, differ between each genus. We reasoned that
the orthologs of FCGR3A and FCGR3B would show
evidence of positive selection in tree branches that have
had high levels of helminth infection. We also reasoned
that amino acids under positive-selection pressure would
be involved in the interaction with IgG and overlap with
the amino acids distinguishing the HNA1a and HNA1b
alleles in humans. We identified putative FCGR3 orthologs
in 26 mammalian species and constructed a maximum-
likelihood phylogenetic tree from these coding sequences
(Figure 3). This tree suggests that both chimpanzees and
gibbons have duplicated FCGR3. Grouping together paral-
ogs rather than orthologs suggests that the duplications are
recurrent in each species lineage. Alternatively, the dupli-
cation might have occurred in the ape ancestor and might
have been homogenized within the species by gene
conversion. The lack of duplication in the orangutan could
then be a result of either a loss of a duplication or poor
sequence coverage of the orangutan genome. There appear
to be two paralogous copies of the rabbit FCGR3 ortholog,
which differs by four amino acids; alternatively, these
could be allelic variants.
We measured positive selection by investigating the
pattern of nonsynonymous and synonymous substitution
rates between the FCGR3 orthologs by utilizing the
maximum-likelihood approach implemented by the soft-
ware PAML v.4.4b. We found very strong evidence of
natural selection acting on a subset of amino acids in980 The American Journal of Human Genetics 90, 973–985, June 8, 2FCGR3 (Figure 4 and Table 5). There is also some support
for a model where positive selection has acted more
strongly on certain amino acids in the lineages with
high levels of helminth infection (p ¼ 0.015). The amino
acids identified as being under positive selection were
plotted on the crystal structure of FCGR3B bound to IgG
(Figure 4). Three patches of positively selected amino acids
can be identified. Patch 1 is clearly associated with anti-
body binding, and the presence of histidines in this region
strongly suggests that natural selection for different
binding affinities is mediated by changes in amino-acid-
residue pH. Patch 2 is on a loop region that is close to—
but not directly associated with—the antibody binding
site. It might interact with either the larger antibody
complex or the glycosylation moieties on the Fc domain.
A human polymorphic site within this patch is known to
determine the neutrophil antigen HNA1c (also known as
SH antigen),43 but the effect on IgG binding of HNA1c
is, to our knowledge, not known. The third patch is at
the interdomain site, the cleft between the two domains
of FCGR3. Alteration of residues here is very likely to alter
the orientation of the two domains and, therefore,
binding affinity.
Importantly, a subset of these amino acids is identified
as likely to be subject to positive selection possibly in
response to higher levels of helminth infection (Table 6
and Figure 4). One of these (IV, position 83 in the crystal
structure) is also the amino acid that defines the
HNA1a/b polymorphism (which is associated with
helminth diversity in human populations), is at the012
Figure 3. Phylogenetic Tree of FCGR3 Genes in
Mammals
Maximum-likelihood phylogeny of full-length
FCGR3 coding sequences. Numbers indicate
helminth diversity for that particular genus (see
Material and Methods), and numbers in bold
reflect those genera classified as high helminth
diversity in subsequent analyses. The scale bar
indicates the branch length representing 0.1
nucleotide substitutions per site.interdomain site, and directly contacts the IgG Cg2
region (green residue, Figure 4). Two other amino acids
that contribute to the HNA1a/b polymorphism are also
in the interdomain region, possibly altering the angle of
the domain and, therefore, binding affinity for different
IgG subtypes.Discussion
We show that the CNV of the Fcg-receptor genes in chro-
mosomal region 1q23.3 is mediated by recurrent NAHR
between the two segmental duplications that carry
FCGR3A and FCGR3B. Deletions of FCGR3A or FCGR3B
differ only in the position of the NAHR breakpoint;
FCGR3A deletions are proximal to the gene, and FCGR3B
deletions are distal to the gene. Each deletion allele of theThe American Journal often analyzed from different populations is
the result of an independent mutation
event that appears to occur in two distinct
clusters. This suggests that the CNV has
a highmutation rate and that NAHR events
occur in hotspots.
Using a population-based coalescent
approach, we show that the mutation rate
of the FCGR3 CNV is about 0.1% per gener-
ation. This is lower than the 0.7% rate
observed at another multicopy CNV locus,
the beta-defensin region, probably because
of the unusual genomic structure of that
region.44 However, the rate is equivalent
to that previously observed at some other
complex multicopy CNVs like complement
C4.45 This mutation rate is high enough to
suggest that direct measurement of de novo
CNV events in sperm will be a viable alter-
native approach in directly interrogating
the mutation rate of this locus, although
the large region of potential de novo break-
points will make development of such
assays technically challenging.
We show that pathogen richness is likely
to have influenced patterns of variation at
the Fc receptors in humans. The association
between bacterial pathogen diversity and
an active, expressed Fcg receptor IIC atthe NK cell surface is particularly interesting. NK cells
respond to antibody-antigen complexes by triggering
ADCCmediated by both Fcg receptor IIIA and Fcg receptor
IIC (if expressed), which can then destroy host cells in-
fected by bacteria.46 It is interesting to speculate that
the dramatic interindividual variability of NK-cell-medi-
ated bacterial killing46 is due to the polymorphism of
FCGR2C. FCGR3B expression is restricted to neutrophils,
eosinophils, and mast cells, so the association between
HNA1a allele frequency and viral diversity might be due
to variation in the nature of FCGR3B-mediated degranula-
tion by mast cells and eosinophils or to phagocytosis of
antibody-virus complexes by neutrophils.
We identify helminth pathogens, such as those of the
genus Schistosoma or Ascaris, as a potential source of selec-
tion for Fcg receptors by using both interspecies and intra-
species data. Chronic helminth infection is characterizedHuman Genetics 90, 973–985, June 8, 2012 981
Figure 4. Structure of IgG Binding to the Extracellular Domain of Fcg Receptor IIIB
Color coding is as follows: red, HNA1a/b polymorphism; magenta, positively selected site in mammals (posterior probability > 99%);
green, HNA1a/b polymorphism and positively selected in mammals; yellow, positively selected site in mammals (p > 95%). Also see
Table 6.
(A) Patch 1 and Patch 2 are selected variants highlighted on the space-filling protein structure. An alternative (rotated ~90) view is also
shown and shows Patch 2 and the HNA1 variant.
(B) A view of protein structure, in ribbon format, highlights the interdomain region.
(C) An amino acid sequence alignment of species analyzed shows a predicted secondary structure, positively selected amino acids, and
amino acids likely to have been shaped by helminth diversity.by a type II immune response, which is skewed toward the
production of IgE antibodies and for which signaling
occurs primarily through Fcε receptors.47 However, eosino-
phils play a key role in the type II immune response and
help contain the infection by binding IgG-coated parasites
via Fcg receptors and stimulating ADCC.48–50 For FCGR2C
and FCGR3B, we show that helminth diversity is correlated
with the tested polymorphisms. FCGR3B is expressed on
eosinophils, and FCGR2C is expressed on NK cells also
involved in mediating ADCC. This is consistent with
a model in which a variable level of chronic helminth
infection has provided a selective pressure on these genes
between human populations.
Helminths are thought to have coexisted with mammals
throughout mammalian evolution and are known to
modulate the immune system with immunosuppressive
activity.51 We show that certain amino acids of Fcg
receptor III have evolved rapidly duringmammalian evolu-
tion and that this pattern might be explained by differ-982 The American Journal of Human Genetics 90, 973–985, June 8, 2ences in helminth diversity between different species.
Furthermore, one of the positively selected amino acids
also constitutes the HNA1a/b polymorphism associated
with helminth diversity, and several positively selected
amino acids directly interact with IgG. The HNA1c poly-
morphism, which is rare (2.5%), at least in Europeans,43
is also determined by variation at an amino acid that has
undergone positive selection in mammals. This variant
should be a priority for further functional and genetic
studies.
All together, these data suggest that alterations to IgG
binding in the context of helminth infection have driven
positive selection in Fcg receptors among different
mammalian species. It has been suggested previously that
malaria has affected the frequency of polymorphisms at
these loci.52Wefindno correlationbetweenprotozoadiver-
sity and allele frequency at these polymorphisms, but such
a correlationwould be expected if malaria were acting as an
agent of natural selection and is indeed observed at other012
Table 5. PAML Analysis of Positive Selection on FCGR3 in Mammals
Test for
Null Hypothesis (H0) Alternative Hypothesis (H1)
p Value u2
Proportion of
Sites under
SelectionModel Parameters Log Likelihood Model Parameters Log Likelihood
Variable selection
between codons
0 u 8,068.63 3 u0, u1, u2 7,806.75 4.9 3 10112 >1.86 0.21
Positive selection 1a 0 < u0 <1,
u1 ¼ 1
7,854.90 2a 0 < u0 <1,
u1 ¼ 1,
u2 R 1
7,820.03 7.2 3 1016 2.62 0.11
Positive selection 7 p, q 7,840.73 8 p, q, u2 R 1 7,804.38 1.6 3 1016 2.14 0.14
Positive selection
on high helminth
branches
Anull 0 < u0 <1,
u1 ¼ 1, u2 ¼ 1
on high helminth
branches
7,851.75 A 0 < u0 <1,
u1 ¼ 1, u2 R 1
on high helminth
branches
7,848.84 0.0158 3.81 0.053known loci associated with malaria.37 Similarly, two
different measures of malaria prevalence showed no corre-
lationwith allele frequencies. Therefore,wefindno support
for this hypothesis, although this does not, of course,
contradict the fact that genetic variation at these loci affects
malaria susceptibility in current populations.20
Our conclusions from the genetic data should prompt
further analysis of the role of Fcg receptors in helminth
infection. Importantly, our model explicitly links evolu-
tionary pressure of helminth infection with autoimmune
disease via adaptation at the genetic level. It supports the
hygiene hypothesis, which states that in the absence of
chronic helminth infection, as seen in modern first-
world populations, previously selected alleles respond
differently to immune-system challenges and therefore
alter the susceptibility to autoimmune disease.23,53 It
also points toward genetic and evolutionary investiga-
tion of complex structurally variable genomic regionsTable 6. FCGR3 Amino Acid Residues Identified as Being under Positiv
Amino Acid
Position
(Crystal
Structure)
Position
(Species
Alignment)
Selection
Posterior
Probability
Asso
with
Rich
Ser or Arg 18 36 NS no
Leu 20 38 NS no
Ser 24 42 1.000 yes
Ser or Asn 47 65 NS no
Asp 59 78 0.999 no
Ala or Asp 60 79 0.996 no
Asn or Asp 64 83 NS no
Ile or Val 88 107 0.999 yes
His 119 163 0.992 yes
His 135 179 0.990 no
Ile NA 226 0.995 no
Ser NA 228 0.962 yes
The following abbreviations are used: NS, not significant; and NA, not available.
The Amthat contain immune genes, of which there are
many,54 as an approach to finding disease susceptibility
alleles.Supplemental Data
Supplemental Data include one figure and four tables and can be
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